Meloxicam 15 mg is a prescription anti-inflammatory drug used primarily to treat pain and stiffness from osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) but differs from older options like ibuprofen and naproxen in one meaningful way: it preferentially targets the enzyme most responsible for inflammation while being somewhat gentler on the stomach. That selectivity, along with its once-daily dosing, is a big part of why it became one of the most commonly prescribed NSAIDs worldwide.
The Conditions Meloxicam 15 mg Treats
Meloxicam has been approved in more than 80 countries for the treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.1JAMA Internal Medicine. Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial In the United States, the 15 mg tablet is the highest standard oral dose and is typically reserved for situations where the lower 7.5 mg dose does not provide enough relief.
Osteoarthritis is far and away the most common reason people are prescribed meloxicam. The disease breaks down cartilage in joints over time, leading to chronic pain and stiffness, especially in the knees, hips, and hands. Rheumatoid arthritis is an autoimmune condition where the immune system attacks joint linings, causing swelling and eventually joint damage. Ankylosing spondylitis mainly affects the spine and sacroiliac joints, producing back stiffness that is often worse in the morning. In all three conditions, the underlying driver of symptoms is inflammation, and that is where meloxicam steps in.
Beyond these approved uses, doctors sometimes prescribe meloxicam off-label for other pain problems that involve musculoskeletal inflammation. Low back pain is a common example. Oral meloxicam has a long track record of use for various pain syndromes of skeletomuscular origin.2PubMed Central. Meloxicam in the management of post-operative pain: Narrative review Clinicians also use it to manage post-surgical pain in some settings, though newer injectable formulations are sometimes preferred there. The point is that while the label says arthritis, the drug’s anti-inflammatory effect makes it useful for a broader range of painful inflammatory conditions.
How Meloxicam Works Inside the Body
Your body produces enzymes called cyclooxygenase, or COX, which come in two main forms. COX-1 is active all the time and plays a protective role, particularly in maintaining the stomach lining and supporting normal kidney function. COX-2, on the other hand, ramps up when tissue is injured or inflamed. It drives the production of prostaglandins, the chemical messengers that cause swelling, pain, and fever at the site of inflammation.
Most traditional NSAIDs block both COX-1 and COX-2 without much discrimination. That is why drugs like ibuprofen and naproxen are effective at reducing pain and swelling but can also irritate the stomach: they suppress the protective prostaglandins along with the inflammatory ones. Meloxicam consistently shows selectivity toward COX-2, meaning it preferentially blocks the inflammation-driving enzyme while having less impact on COX-1.3Springer Link. Meloxicam: selective COX-2 inhibition in clinical practice The result is that you still get significant anti-inflammatory and pain-relieving effects, but the drug is somewhat less likely to cause the stomach problems that make older NSAIDs hard for some people to tolerate.
It is worth noting that “preferential” is not the same as “exclusive.” Meloxicam does still have some COX-1 activity, which is why stomach-related side effects can still happen, just at lower rates than with non-selective NSAIDs. This makes meloxicam different from the highly selective COX-2 inhibitors like celecoxib, which were designed to have almost no COX-1 activity. Meloxicam sits in between the old-school NSAIDs and the fully selective ones.
Why 15 mg and Not a Different Dose
Meloxicam is typically available in 7.5 mg and 15 mg tablets. In a 12-week trial comparing meloxicam at multiple dose levels against placebo and diclofenac (another well-known NSAID), both the 7.5 mg and 15 mg daily doses were significantly more effective than placebo for pain and stiffness endpoints in osteoarthritis. A lower 3.75 mg dose did not consistently reach significance for all measures. Pain relief became apparent after about two weeks and improved with increasing doses, holding steady through the end of the trial.1JAMA Internal Medicine. Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial
In practice, most prescribers start patients at 7.5 mg once daily and move to 15 mg only if the lower dose is not enough. The reasoning is straightforward: use the smallest effective dose to minimize the risk of side effects. If 7.5 mg controls your symptoms adequately, there is no benefit to doubling it. The 15 mg dose is essentially the ceiling for standard oral meloxicam. Going higher does not produce proportionally better relief but does increase the chances of adverse effects.
One of the practical advantages of meloxicam at either dose is that you only take it once a day. Its long half-life in the body, roughly 20 hours, means a single morning or evening dose keeps drug levels relatively stable throughout the day. Compare that to ibuprofen, which you might need to take every six to eight hours, and you can see why once-daily dosing appeals to people managing chronic conditions.
The Stomach Safety Question
Gastrointestinal problems are the most common complaint with NSAIDs as a class. Stomach pain, nausea, ulcers, and in rare cases serious GI bleeding all show up with long-term use. This is where meloxicam’s COX-2 preference gives it a measurable edge. A systematic review and meta-analysis of randomized trials found that patients using meloxicam had fewer GI adverse events compared with non-COX-2-selective NSAIDs, with an odds ratio of about 0.64.4PubMed Central. Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials In plain terms, that means roughly a third fewer GI problems compared with traditional NSAIDs across the studies analyzed.
That is meaningful, but it does not mean meloxicam is gentle on everyone’s stomach. People with a history of ulcers, GI bleeding, or who take blood thinners still face real risk. Many doctors will prescribe a proton pump inhibitor alongside meloxicam for patients at elevated GI risk, essentially adding stomach protection to offset the NSAID’s residual effects. If you have had stomach problems with NSAIDs before, the lower rate of GI events with meloxicam is encouraging but not a guarantee you will be trouble-free.
Cardiovascular Risks You Should Know About
All NSAIDs carry a boxed warning about cardiovascular risk, and meloxicam is no exception. The FDA-approved labeling states plainly that NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, including heart attack and stroke, and that this risk may increase with duration of use.5DailyMed. MELOXICAM- meloxicam tablet That warning applies whether you are on the drug for two weeks or two years, though the concern grows the longer you take it.
For someone using meloxicam to manage a short flare of joint pain, this risk is very small. For someone who has been taking it daily for months or years to control chronic arthritis, the cumulative risk deserves a real conversation with a doctor, especially if you already have heart disease, high blood pressure, or other cardiovascular risk factors. The warning does not mean everyone on meloxicam will have a heart attack. It means the risk is non-zero, it is dose- and duration-dependent, and it should be weighed against the benefit the drug is providing.
People sometimes assume that because meloxicam is “gentler” than older NSAIDs on the stomach, it must be safer across the board. That is a misconception. The GI advantage does not translate into a cardiovascular advantage. In fact, the broader story of COX-2 selective drugs includes the withdrawal of rofecoxib (Vioxx) in 2004 after it was linked to elevated heart attack risk. Meloxicam is not in the same chemical family and has a different selectivity profile, but the episode made the entire medical community more cautious about cardiovascular monitoring with any NSAID.
Kidney Effects and Fluid Retention
COX enzymes also play a role in maintaining blood flow to the kidneys. When you suppress them with any NSAID, including meloxicam, you can reduce the kidney’s ability to manage sodium and water balance. The practical result is that some people notice swelling in the ankles or feet, a slight bump in blood pressure, or both. For most healthy adults, this effect is mild and reversible once the drug is stopped.
For people who already have kidney disease, heart failure, or are on diuretics (water pills), the stakes are higher. NSAIDs can push borderline kidney function into a more concerning range. If you are taking meloxicam long-term, your doctor will likely check your kidney function periodically with a simple blood test. Staying well hydrated and avoiding other nephrotoxic drugs at the same time helps reduce the risk. This is not unique to meloxicam; it is a class effect shared by all NSAIDs, but it is easy to forget because the drug is so commonly used.
Who Should Avoid Meloxicam
Certain groups face enough risk that meloxicam is either contraindicated or requires extra caution:
- People with active GI bleeding or ulcers: Any NSAID can worsen an existing bleed, and meloxicam’s partial COX-1 sparing is not protective enough to make it safe in that scenario.
- Late pregnancy: NSAIDs can cause premature closure of the ductus arteriosus in the developing fetus and are generally avoided from about 20 weeks of pregnancy onward.
- Severe kidney or liver impairment: Reduced clearance of the drug means it can accumulate to unsafe levels, and the kidneys are already vulnerable.
- People with known NSAID allergy: Some individuals develop asthma attacks, hives, or anaphylaxis-like reactions to one NSAID and are at risk of cross-reactivity with others, including meloxicam.
- Patients on blood thinners like warfarin: The combination raises the risk of bleeding, especially from the GI tract.
Age alone is not a contraindication, but older adults are more likely to have the overlapping risk factors (reduced kidney function, cardiovascular disease, prior GI problems) that make long-term NSAID use more hazardous. The general principle is to use the lowest effective dose for the shortest possible time, which is good advice for any NSAID, not just meloxicam.
How Meloxicam Compares to Over-the-Counter Options
If meloxicam works by reducing inflammation, and so do ibuprofen and naproxen, a reasonable question is why you would need a prescription for meloxicam at all. The differences come down to selectivity, duration, and the clinical profile.
Ibuprofen and naproxen block COX-1 and COX-2 more or less equally. They are effective for short-term pain relief, but their non-selective action means they carry a higher GI risk per dose when used regularly. Meloxicam’s COX-2 preference lowers that GI burden, which matters when someone needs daily anti-inflammatory therapy for weeks or months. The once-daily dosing is another practical difference. People managing chronic arthritis are more likely to stay consistent with a single daily tablet than with something they need to remember three times a day.
Acetaminophen (Tylenol) is the other common comparison. It relieves pain and reduces fever but has essentially no anti-inflammatory effect. For conditions where inflammation is the primary driver of symptoms, like the arthritic diseases meloxicam is approved for, acetaminophen alone is often not enough. It is sometimes used alongside meloxicam on an as-needed basis for breakthrough pain, since it works through a different mechanism and does not compound the NSAID-specific risks.
Common Drug Interactions
Meloxicam interacts with several widely used medications, and some of these interactions are easy to miss because the other drugs are so common.
- Blood pressure medications: NSAIDs can blunt the effect of ACE inhibitors, ARBs, and diuretics by promoting sodium retention. If you start meloxicam and notice your blood pressure creeping up, this interaction is a likely reason.
- Aspirin: Low-dose aspirin taken for heart protection may have its antiplatelet effect partially blocked by concurrent NSAID use. The clinical significance varies, but the interaction is real enough that some guidelines recommend taking aspirin at least 30 minutes before meloxicam if both are necessary.
- SSRIs and SNRIs: These common antidepressants can increase bleeding risk on their own. Adding an NSAID compounds that risk, particularly in the GI tract.
- Lithium and methotrexate: Meloxicam can raise blood levels of both drugs by reducing their renal clearance, potentially leading to toxicity. Patients on either medication usually need closer monitoring.
None of these interactions make it impossible to use meloxicam, but they do mean your prescriber needs the full picture of what you are already taking. Over-the-counter NSAIDs like ibuprofen should generally be avoided while on meloxicam, since stacking two NSAIDs increases side-effect risk without proportional benefit.
What to Expect When You Start Taking It
Meloxicam is not a fast-acting pain reliever in the way that popping an ibuprofen or acetaminophen can be. While some people notice improvement within a few days, the clinical trial evidence suggests that meaningful efficacy becomes apparent after about two weeks and continues to build from there.1JAMA Internal Medicine. Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial If you have been on it for only a few days and feel underwhelmed, that is normal. The drug needs time to lower the baseline level of inflammation in your joints.
Taking meloxicam with food or a full glass of water can help reduce stomach irritation, though the drug is absorbed well either way. Alcohol increases the risk of GI bleeding with any NSAID, so limiting or avoiding it while on meloxicam is a practical step that reduces one of the more common side effects. If you experience dark or tarry stools, persistent stomach pain, or unexplained shortness of breath while on meloxicam, those warrant prompt medical attention, as they can signal GI bleeding or cardiovascular complications.